临床器官运输系统供应商TransMedics集团(TMDX)今日盘中股价大涨5.64%,引发市场广泛关注。这种上涨首要源于公司业绩增长强劲,以及所处行业前景看好。
公司最新财报显示,营业收入和净利润均保持稳健增长,70%机构给予公司"买入"评级。随着医疗技术的发展,临床器官供给严重不足的问题逐渐凸显,生理状态下的长途器官运输成为刚需。TransMedics在这一细分市场处于垄断地位,竞争对手寥寥无几。
同时,整个医疗器械板块今日也是普遍上涨,上游原材料价格回落、行业监管政策利好有望进一步推动医疗器械企业盈利能力改善。这一背景下,TransMedics等科创龙头股备受资金追捧,股价持续走强实属不足为奇。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.